0

Close
 
Upcoming Allied Market Research
2023
Neurovascular Catheters Market

Neurovascular catheters Market: Global Opportunity Analysis and Industry Forecast 2023-2030 Market

LS : Medical Devices & Supplies
Report Code: A10298
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Neurovascular Catheters Market

Request Now !

Catheters are a medical device that has a structure like a tube and is slide in the cavity of the body for therapeutic or diagnostic segments. By utilizing the neurovascular catheters unwanted fluids can be drawn from the neurovascular organs like the carotid artery, brain, and intracranial spaces which help in the medications administrations of the organs along with the diagnosis of the neurovascular diseases like carotid artery disease and brain aneurysms.

Neurovascular catheters Market

Neurovascular catheters also help in carrying the neurovascular devices to the neurovascular organs, brain for instance. Consequently, neurovascular catheters are applied in various cranial procedures. There has been a significant rise in the number of neurological procedures gradually increasing the consumption of neurovascular catheters. Additionally, there have been various innovations for the treatments of ischemic stroke that include the flow diverting stents and stent retrievers which are helping the production of catheters as well.

COVID-19 scenario analysis:

To take care of the infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With a rise in the number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil populations for precautionary measures. Manufacturers of these products have a chance to capitalize on this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market.

Owing to such factors, COVID 19 is expected to have a significant impact on the Neurovascular catheters market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Neurovascular catheters are used for the treatment of the stroke along with the neurovascular devices. Factors like urbanization, stressful and sedentary lifestyle are responsible for increasing the strokes count globally, thus increasing the number of operations and consumptions of neurovascular catheters. These are the major factors propelling the growth of the neurovascular catheters market. 

Moreover, awareness has been rising for the treatments available for the patients' reimbursement policies getting better over the period, upgrades in the devices, are also some of the other factors affecting the neurovascular catheters market.       

Additionally, the advancement in the ergonomic designs and better efficiency in the clinical field is helping the growth of the neurovascular catheters market.

On the other hand, certain factors are limiting the acceptance of neurovascular catheters. These include the rate of treatments for neurovascular diseases are significantly low in developing economies. The lower rates are due to the expensive cost of the operations and the scarcity of various policies for the reimbursement. Moreover, the applications of the catheters and the risk associated with them are posing a threat to the consumption of neurovascular catheters. There are also several other risk factors like the blockage of the catheter, compatibility issues of the catheters are some of the other challenges hampering the growth of the neurovascular catheters market.

New product launches and acquisitions to flourish the market:

On February 20th, 2020: IWG High Performance Conductors was acquired by Teleflex which is a manufacturer of medical devices. This acquisition helped Teleflex enhance their portfolio.

On May 1st, 2019, Medtronic introduced Solitaire X which is a revascularization device. This device is helping the treatment of patients who suffer from acute ischemic stroke because it removes all the blood clotsand the blood flow efficiently.

Surge in usage in hospitals and clinics segment applications:

The hospitals and specialty clinics are the major consumers of the neurovascular catheters market. Amongst them, the hospitals are the biggest end-users. This is due to the higher procedures performed in hospitals for neurovascular disorders. 

Alongside, specialty clinics are also growing nowadays in respect to the neurovascular catheters.

Key benefits of the report:

  • This study presents the analytical depiction of the global Neurovascular catheters industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Neurovascular catheters market share.
  • The current market is quantitatively analyzed to highlight the global market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Neurovascular catheters market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Neurovascular catheters Market research report:

  • What are the leading market players active in the Neurovascular catheters market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

 Neurovascular catheters Market: Global Opportunity Analysis and Industry Forecast 2020–2027 Report Highlights

Aspects Details
By Type
  • Microcatheters
  • Balloon Catheters
  • Thrombectomy Catheters
  • Others
By Application
  • Hemorrhagic Stroke
  • Ischemic Stroke
By End User
  • Hospitals
  • Specialty Clinics
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Stryker, , Integra Life Sciences Corporation, Biomerics, DePuy Synthes, Medtronic, Integer Holdings Corporation, Concentric Medical, Inc.., Johnson and Johnson company, Zeus Industrial Products, Inc., RAUMEDIC AG
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: NEUROVASCULAR CATHETERS MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Microcatheters

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Balloon Catheters

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Thrombectomy Catheters

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROVASCULAR CATHETERS MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Hemorrhagic Stroke

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Ischemic Stroke

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROVASCULAR CATHETERS MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Specialty Clinics

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROVASCULAR CATHETERS MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Neurovascular Catheters Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Neurovascular Catheters Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Neurovascular Catheters Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Neurovascular Catheters Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Neurovascular Catheters Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Neurovascular Catheters Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Neurovascular Catheters Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Neurovascular Catheters Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Neurovascular Catheters Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Neurovascular Catheters Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Neurovascular Catheters Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Neurovascular Catheters Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Neurovascular Catheters Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Neurovascular Catheters Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Neurovascular Catheters Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Neurovascular Catheters Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Neurovascular Catheters Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Neurovascular Catheters Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Neurovascular Catheters Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Neurovascular Catheters Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Neurovascular Catheters Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Neurovascular Catheters Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Neurovascular Catheters Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Neurovascular Catheters Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Neurovascular Catheters Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Stryker

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Medtronic

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Integer Holdings Corporation

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. DePuy Synthes

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. , Integra Life Sciences Corporation

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Biomerics

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Zeus Industrial Products, Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. RAUMEDIC AG

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Concentric Medical, Inc..

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Johnson And Johnson Company

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR MICROCATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR BALLOON CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR THROMBECTOMY CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL NEUROVASCULAR CATHETERS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR HEMORRHAGIC STROKE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR ISCHEMIC STROKE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR CATHETERS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR CATHETERS MARKET FOR SPECIALTY CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR CATHETERS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA NEUROVASCULAR CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. U.S. NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. U.S. NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. CANADA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. CANADA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. CANADA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE NEUROVASCULAR CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. FRANCE NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. FRANCE NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. FRANCE NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. ITALY NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. ITALY NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. ITALY NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. SPAIN NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. UK NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. UK NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. UK NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. RUSSIA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. RUSSIA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. RUSSIA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC NEUROVASCULAR CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. CHINA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. CHINA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. CHINA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. JAPAN NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. INDIA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. INDIA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. INDIA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. AUSTRALIA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. AUSTRALIA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. THAILAND NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. THAILAND NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. THAILAND NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. MALAYSIA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. MALAYSIA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. MALAYSIA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. INDONESIA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 77. INDONESIA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 78. INDONESIA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. LAMEA NEUROVASCULAR CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. LAMEA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. BRAZIL NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. BRAZIL NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. BRAZIL NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH AFRICA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH AFRICA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH AFRICA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. SAUDI ARABIA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 93. SAUDI ARABIA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 94. SAUDI ARABIA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 95. UAE NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 96. UAE NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. UAE NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. ARGENTINA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. ARGENTINA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. ARGENTINA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. REST OF LAMEA NEUROVASCULAR CATHETERS, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 102. REST OF LAMEA NEUROVASCULAR CATHETERS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. REST OF LAMEA NEUROVASCULAR CATHETERS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. STRYKER: KEY EXECUTIVES
  • TABLE 105. STRYKER: COMPANY SNAPSHOT
  • TABLE 106. STRYKER: OPERATING SEGMENTS
  • TABLE 107. STRYKER: PRODUCT PORTFOLIO
  • TABLE 108. STRYKER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. MEDTRONIC: KEY EXECUTIVES
  • TABLE 110. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 111. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 112. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 113. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. INTEGER HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 115. INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 116. INTEGER HOLDINGS CORPORATION: OPERATING SEGMENTS
  • TABLE 117. INTEGER HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 118. INTEGER HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. DEPUY SYNTHES: KEY EXECUTIVES
  • TABLE 120. DEPUY SYNTHES: COMPANY SNAPSHOT
  • TABLE 121. DEPUY SYNTHES: OPERATING SEGMENTS
  • TABLE 122. DEPUY SYNTHES: PRODUCT PORTFOLIO
  • TABLE 123. DEPUY SYNTHES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. , INTEGRA LIFE SCIENCES CORPORATION: KEY EXECUTIVES
  • TABLE 125. , INTEGRA LIFE SCIENCES CORPORATION: COMPANY SNAPSHOT
  • TABLE 126. , INTEGRA LIFE SCIENCES CORPORATION: OPERATING SEGMENTS
  • TABLE 127. , INTEGRA LIFE SCIENCES CORPORATION: PRODUCT PORTFOLIO
  • TABLE 128. , INTEGRA LIFE SCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. BIOMERICS: KEY EXECUTIVES
  • TABLE 130. BIOMERICS: COMPANY SNAPSHOT
  • TABLE 131. BIOMERICS: OPERATING SEGMENTS
  • TABLE 132. BIOMERICS: PRODUCT PORTFOLIO
  • TABLE 133. BIOMERICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. ZEUS INDUSTRIAL PRODUCTS, INC.: KEY EXECUTIVES
  • TABLE 135. ZEUS INDUSTRIAL PRODUCTS, INC.: COMPANY SNAPSHOT
  • TABLE 136. ZEUS INDUSTRIAL PRODUCTS, INC.: OPERATING SEGMENTS
  • TABLE 137. ZEUS INDUSTRIAL PRODUCTS, INC.: PRODUCT PORTFOLIO
  • TABLE 138. ZEUS INDUSTRIAL PRODUCTS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. RAUMEDIC AG: KEY EXECUTIVES
  • TABLE 140. RAUMEDIC AG: COMPANY SNAPSHOT
  • TABLE 141. RAUMEDIC AG: OPERATING SEGMENTS
  • TABLE 142. RAUMEDIC AG: PRODUCT PORTFOLIO
  • TABLE 143. RAUMEDIC AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. CONCENTRIC MEDICAL, INC..: KEY EXECUTIVES
  • TABLE 145. CONCENTRIC MEDICAL, INC..: COMPANY SNAPSHOT
  • TABLE 146. CONCENTRIC MEDICAL, INC..: OPERATING SEGMENTS
  • TABLE 147. CONCENTRIC MEDICAL, INC..: PRODUCT PORTFOLIO
  • TABLE 148. CONCENTRIC MEDICAL, INC..: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. JOHNSON AND JOHNSON COMPANY: KEY EXECUTIVES
  • TABLE 150. JOHNSON AND JOHNSON COMPANY: COMPANY SNAPSHOT
  • TABLE 151. JOHNSON AND JOHNSON COMPANY: OPERATING SEGMENTS
  • TABLE 152. JOHNSON AND JOHNSON COMPANY: PRODUCT PORTFOLIO
  • TABLE 153. JOHNSON AND JOHNSON COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROVASCULAR CATHETERS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROVASCULAR CATHETERS MARKET
  • FIGURE 3. SEGMENTATION NEUROVASCULAR CATHETERS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROVASCULAR CATHETERS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROVASCULAR CATHETERS MARKET
  • FIGURE 11. NEUROVASCULAR CATHETERS MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. NEUROVASCULAR CATHETERS MARKET FOR MICROCATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NEUROVASCULAR CATHETERS MARKET FOR BALLOON CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NEUROVASCULAR CATHETERS MARKET FOR THROMBECTOMY CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. NEUROVASCULAR CATHETERS MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. NEUROVASCULAR CATHETERS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 17. NEUROVASCULAR CATHETERS MARKET FOR HEMORRHAGIC STROKE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. NEUROVASCULAR CATHETERS MARKET FOR ISCHEMIC STROKE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. NEUROVASCULAR CATHETERS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 20. NEUROVASCULAR CATHETERS MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. NEUROVASCULAR CATHETERS MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: NEUROVASCULAR CATHETERS MARKET
  • FIGURE 28. Top player positioning, 2022
  • FIGURE 29. STRYKER: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. STRYKER: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. STRYKER: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. INTEGER HOLDINGS CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. INTEGER HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. INTEGER HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. DEPUY SYNTHES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. DEPUY SYNTHES: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. DEPUY SYNTHES: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. , INTEGRA LIFE SCIENCES CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. , INTEGRA LIFE SCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. , INTEGRA LIFE SCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. BIOMERICS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. BIOMERICS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. BIOMERICS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. ZEUS INDUSTRIAL PRODUCTS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. ZEUS INDUSTRIAL PRODUCTS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. ZEUS INDUSTRIAL PRODUCTS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. RAUMEDIC AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. RAUMEDIC AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. RAUMEDIC AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. CONCENTRIC MEDICAL, INC..: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. CONCENTRIC MEDICAL, INC..: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. CONCENTRIC MEDICAL, INC..: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. JOHNSON AND JOHNSON COMPANY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. JOHNSON AND JOHNSON COMPANY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. JOHNSON AND JOHNSON COMPANY: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Neurovascular Catheters Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers